Figure 5. A, Western blot validation of four candidate proteins (BPGM CFL1, PRDX2, TPI1) from acute phase of RSV infection, convalescence phase, and control samples. Each group included 10 biological replicates and GAPDH was used as an internal control. B, Analysis of the western blot band intensities of candidate proteins in panel A, and comparison of expression levels between RSV infection and control groups. *P<0.05, **P<0.01, ***P<0.001 compared to control (ANOVA with the Dunnett post hoc test). C, Trends in expression levels of candidate proteins in the three groups. Data are reported as means±SD of 10 biological replicates. RSV: respiratory syncytial virus.
